期刊文献+

慢性肾脏病患者动态血压参数及血压变异的特点分析 被引量:4

Features of ambulatory blood pressure and blood pressure variability in patients with chronic kidney disease
下载PDF
导出
摘要 目的 分析慢性肾脏病(chronic kidney disease,CKD)患者动态血压参数与肾小球滤过率(GFR)及尿蛋白定量的相关性,并探讨血压变异性参数特点.方法 收集首次治疗的伴有高血压及蛋白尿的CKD患者70例.测量肾功能、24 h尿蛋白定量等生化检测结果,采用动态血压监测仪监测24 h血压并记录参数.根据GFR将患者分为CKD1~2期组和CKD3~5期组.根据24 h尿蛋白定量分为以下3组:Ⅰ组<1.0 g,Ⅱ组1.0~3.5 g,Ⅲ组>3.5 g.比较各组动态血压参数,并探讨监测结果与肾功能及蛋白尿的关系.结果 随着患者肾功能恶化,24 h收缩压、舒张压、脉压差、白昼收缩压、夜间收缩压等指标明显升高(P<0.05),且与GFR成负相关,白昼收缩压是GFR下降的独立危险因素.Ⅲ组的白昼舒张压(92.94±15.32)mm Hg明显高于Ⅰ组的(85.25±8.64)mm Hg(P<0.05).白昼舒张压与蛋白尿水平呈正相关(r=0.257,P=0.032).所有患者舒张压变异性均明显高于收缩压变异性(P<0.05).结论 本研究样本中收缩压与肾功能恶化明显相关,白昼收缩压和舒张压分别与GFR下降及蛋白尿有关,舒张压变异性应受到更多重视. Objective To explore the features of ambulatory blood pressure and blood pressure variability in patients with chronic kidney disease (CKD). Methods A total of 70 initially diagnosed CKD patients with hypertension and proteinuria in our department were enrolled in this study. Ambulatory blood pressure was monitored. Serum creatinine, 24-h urinary protein quantitation and other biochemical parameters were measured regularly. According to GFR, patients were divided into CKD1-2 stage group and CKD3-5 stage group. In the light of 24-h urinary protein quantitation, patients were divided into three groups., group Ⅰ (〈1.0 g), group Ⅱ (1.0-3. 5 g), group Ⅲ (〉3.5 g). Results With the deterioration of renal function, 24-h systolic blood pressure, diastolic blood pressure, pulse pressure, daytime systolic blood pressure, nighttime systolic blood pressure and other indicators were significantly increased, and these indicators were negatively correlated with GFR. Daytime systolic blood pressure was an independent risk factor for GFR decline. The daytime diastolic blood pressure in group Ⅲ[(92. 94 ± 15.32) mmHg] was significantly higher than in group Ⅰ [(85.25 ± 8. 64) mmHg] (P〈0. 05). Daytime diastolic blood pressure level was positively correlated with proteinuria (r = 0. 257,P = 0. 032). The diastolic blood pressure variability was higher than the systolic blood pressure variability in all patients (P〈0. 05). Conclusions Systolic blood pressure is significantly associated with deterioration of renal function. Daytime systolic and diastolic blood pressure is associated with the decline of GFR and proteinuria, respectively. More attention should be paid to diastolic blood pressure variability.
出处 《临床肾脏病杂志》 2013年第11期511-514,共4页 Journal Of Clinical Nephrology
关键词 慢性肾脏病 高血压 血压监测 变异性 Chronic kidney disease Hypertension Blood pressure monitoring Variability
  • 相关文献

参考文献15

  • 1Zhang L,Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 3: 815- 822.
  • 2Muntner P, He J, Astor BC, et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney dis- ease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol, 2005,16 : 529-538.
  • 3Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kid- ney disease in a community-based population. JAMA, 2004, 18: 844-850.
  • 4Agarwal R,Andersen MJ. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension, 2005,46 : 514- 52O.
  • 5李军辉,马南,简桂花,王锋,俞岗,薛勤,高许萍,汪年松.慢性肾脏病患者24小时动态血压的特点分析[J].临床肾脏病杂志,2011,11(10):460-462. 被引量:5
  • 6Palmas W,Pickering T,Teresi J, et al. Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens(Greenwich) ,2008,10.- 12- 20.
  • 7Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet, 2010,13 : 895-905.
  • 8Eguchi K, Hoshide S, Schwartz JE, et al. Visit-to visit and ambu- latory blood pressure variability as predictors of incident cardio vascular events in patients with hypertension. Am J Hypertens, 2012,25 : 962-968.
  • 9Hastie CE, Jeemon P, Coleman H, et al. Long-term and ultra long-term blood pressure variability during follow-up and mortal- ity in 14,522 patients with hypertension. Hypertension~ 2013,62 : 698-705.
  • 10Suchy-Dicey AMy Wallace ER, Mitchell SV, et al. Blood pressure variability and the risk of all cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens, 2013,26 : 1210-1217.

二级参考文献11

  • 1李娅,冯晓蓓,章倩莹,任红,张文,陈晓农,陈楠.慢性肾脏病患者血压昼夜节律异常的研究[J].中华肾脏病杂志,2006,22(6):328-331. 被引量:40
  • 2National Kidney Foundation. K/I)OQI clinical practice guideline on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis,2004,43: S1-S290.
  • 3National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis, 2002,39: S1 -S266.
  • 4Rajiv A. Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Semin Nephroll, 2007,27 : 538-543.
  • 5Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension, 2005,45: 1119-1124.
  • 6Sherwood A, Steffen PR, Blumenthal JA, et al. Nighttime blood pressure dipping:The role of the Sympathetic nervous system. Am J Hypertens,2002,15:111-118.
  • 7Brotman DJ, Girod JP, Thomas S. Increase in nocturnal blood pressure and progression to microalbuminuia in diabetes. N Engl J Med, 2003,348: 260-264.
  • 8Davidson MB, Hix JK, Vidt DG, et al. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Interned, 2006,166: 846-852.
  • 9Agarwal K, Anderson MJ. Correlate of systolic hypertension in patients with chronic kidney disease. Hypertension, 2005, 46: 514-520.
  • 10Papagianni A, Kokolina E, Kalovoulos M, et al. Carotid athero- sclerosis is associated with inflammation, malnutrition and intercellular adhesion moleeulel in patients on continuous ambulatory Peritoneal dialysis. Nephrol Dial Transplan, 2004,19 : 1258-1263.

共引文献4

同被引文献42

  • 1苏定冯.血压变异性与高血压的治疗[J].中华心血管病杂志,2005,33(9):863-865. 被引量:109
  • 2Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data[J]. Lancet, 2005, 365(9945): 217-223.
  • 3Chobanian AV, Bakris GL, Black HR, et al. Seventh report of theJoint national committee on prevention, detection, evaluation, and treatment of high blood pressure[J]. Hypertension, 2003, 289(19): 1206-1252.
  • 4Esler M. The sympathetic system and hypertension[J]. Am 1 Hypertens , 2000, 13(6): 99S-105S.
  • 5Krum H, Schlaich M, Whitbourn R, et al. Catheter-based re- nal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet, 2009, 373(4): 1275-1281.
  • 6Investigators Symplicity HTN-1. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressurereduction out to 24 months. Hypertensionj I}, 2011,57: 911-917.
  • 7Grassi G, Cattaneo BM, Seravalle G, et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension[J]. Hypertension, 1998, 31(1): 68-72.
  • 8Esler MD, Krum H, Schlaich MR, et al. Sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled triale]]. Circulation, 2012, 126(25): 2976-2982.
  • 9Stephen G, Worthley, Costas P, et al. Safety and efficacy of a multi electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial[J]. European HeartJournal, 2013,34(74): 2132-2140.
  • 10GewirtzJR, BisognanoJD. Catheter-based renal sympathetic denervation, a targeted approach to resistant hypertension[J]. CardiolJ, 2011, 18(1): 97-102.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部